Evotec SE (EVO) Other Non-Current Assets (2020 - 2026)
Evotec SE's (EVO) quarterly Other Non-Current Assets came in at $489.37 in Q1 2026, down 84.24% year-on-year from $3105.2 in Q1 2025, and down 17.08% quarter-over-quarter from $590.17 in Q4 2025.
Evotec SE (EVO) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $489.37 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $489.37, down 84.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $489.37 (down 84.24% YoY), and the FY2025 annual result was $590.17, down 99.98% from the prior year.
- Other Non-Current Assets came in at $489.37 for Q1 2026 at Evotec SE, down from $590.17 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.9 million in Q4 2022 to a low of $489.37 in Q1 2026.
- The 5-year median for Other Non-Current Assets is $3105.2 (2025), against an average of $653186.0.
- Across the five-year window, Other Non-Current Assets jumped 488.42% in 2022 and plunged 99.98% in 2025, its largest moves.
- Evotec SE's Other Non-Current Assets stood at $3.9 million in 2022, then plunged by 76.68% to $900561.7 in 2023, then jumped by 311.03% to $3.7 million in 2024, then slumped by 99.98% to $590.17 in 2025, then slipped by 17.08% to $489.37 in 2026.
- The last three Other Non-Current Assets figures came in at $489.37 (Q1 2026), $590.17 (Q4 2025), and $889.65 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 489.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 489.37 |
| Dec 31, 2025 | 590.17 |
| Sep 30, 2025 | 889.65 |
| Jun 30, 2025 | 1,139.88 |
| Mar 31, 2025 | 3,105.16 |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 8,152.08 |
| Mar 31, 2024 | 924.49 |
| Dec 31, 2023 | 900,561.70 |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 5,891.35 |
| Jun 30, 2022 | 5,453.73 |
| Mar 31, 2022 | 969.70 |
| Dec 31, 2021 | 995,254.73 |
| Sep 30, 2021 | 1,001.21 |
| Dec 31, 2020 | 26,230.38 |